UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-41916
Silynxcom Ltd.
7 Giborei Israel
Netanya, 4250407
Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
CONTENTS
Execution of Sales Agreement
On October 1, 2026, Silynxcom
Ltd. (the “Company”) entered into an ATM Sales Agreement (the “Sales Agreement”) with Think Equity LLC (the “Sales
Agent”), pursuant to which the Company may offer and sell, from time to time, to or through the Sales Agent as agent, ordinary shares,
no par value per share (the “Ordinary Shares”). The Ordinary Shares will be offered and sold pursuant to the Company’s
currently effective registration statement on Form F-3 (File No. 333-285443), the prospectus contained therein and the prospectus supplement
filed with the Securities and Exchange Commission dated October 2, 2026.
The Company is not obligated
to sell any Ordinary Shares under the Sales Agreement. Subject to the terms and conditions of the Sales Agreement, the Sales Agent will
use commercially reasonable efforts consistent with its normal trading and sales practices, applicable state and federal law, rules and
regulations and the rules of the NYSE American to sell Ordinary Shares from time to time based upon the Company’s instructions,
including any price, time or size limits specified by the Company. The Company intends to use the net proceeds from the sale of securities
under the prospectus supplement for working capital and general corporate purposes.
Upon delivery of a placement
notice to the Sales Agent, and subject to the Company’s instructions in that notice, and the terms and conditions of the Sales Agreement
generally, the Sales Agent may sell the Ordinary Shares by any method permitted by law deemed to be an “at the market offering”
as defined by Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended. The Sales Agent may also sell Ordinary Shares in
negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, if authorized
by the Company in writing and subject to the terms of the Sales Agreement. The Sales Agent’s obligations to sell Ordinary Shares
under the Sales Agreement are subject to satisfaction of certain conditions. The Company will pay the Sales Agent a commission of 3.0%
of the aggregate gross proceeds from each sale of Ordinary Shares and has agreed to provide the Sales Agent with customary indemnification
and contribution rights. The Company has also agreed to reimburse the Sales Agent for certain specified expenses. The Sales Agreement
contains customary representations and warranties and conditions to the sale of the shares thereunder.
The Company and the Sales Agent each have the right, in their sole discretion, to terminate the Sales Agreement at any time after the
date of the Sales Agreement by giving five (5) days’ notice to the other party. Certain provisions of the Sales Agreement shall
survive termination, as further described in the Sales Agreement.
The foregoing summary of the
Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the Sales Agreement, which is attached
as Exhibit 10.1 to this Report of Foreign Private Issuer on Form 6-K (this “Report”), and is incorporated herein by reference.
The
copy of the legal opinion of Sullivan & Worcester Tel Aviv (Har-Even & Co.) relating to the legality of the issuance and sale
of the Ordinary Shares that may be sold pursuant to the Sales Agreement is filed as Exhibit 5.1 to this Report.
This Report shall not constitute
an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Ordinary Shares in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.
Incorporation By Reference
This Report is incorporated
by reference into the Company’s Registration Statement on Form F-3 (File No. 333-285443), filed with the Securities and Exchange
Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports
subsequently filed or furnished.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 5.1 |
|
Opinion of Sullivan & Worcester Tel Aviv (Har-Even & Co.) |
| 10.1 |
|
ATM Sales Agreement by and between Silynxcom Ltd. and ThinkEquity LLC, dated October 1, 2026. |
| 23.1 |
|
Consent of Sullivan & Worcester Tel Aviv (Har-Even & Co.) (included in Exhibit 5.1) |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
SILYNXCOM LTD. |
| |
|
|
| Date: October 2, 2026 |
By: |
/s/ Nir Klein |
| |
Name: |
Nir Klein |
| |
Title: |
Chief Executive Officer |
